Fact CheckerSign in

NCT05036135CompletedPhase 2/3

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial (IMPAHCT) or A Phase 2b/3, Randomized, Controlled, 24-week Dose Ranging and Confirmatory Study of AV-101 in Patients with PAH

IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients with Pulmonary Arterial Hypertension (PAH)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 May 2024

Brief summary (registry, in English)

The objective of the study is to establish an optimal dose based primarily upon the change in PVR assessed by right heart catheterization (RHC) and the safety and tolerability of AV-101 as evaluated in the Phase 2b Part of the study. The optimal dose will be taken into the Phase 3 Part of the study where the placebo-corrected change in 6MWD after 24 weeks of treatment will be used as the primary endpoint.

Status (registry)
Completed
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
205 (actual)
First submitted
1 Feb 2024
Start date
Jun 2022
Lead sponsor
Aerovate Therapeutics Inc.
NCT number
NCT05036135
EU CT number
2023-508734-34-00
EudraCT number
2021-001910-13

What you commit to

  • Study type: Interventional · Phase 2/3
  • Participants enrolled: 205
  • 46 sites in 14 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Pulmonary hypertension (PH) belonging to Groups 2 to 5 of the 2018 NICE classification and Group 1 diagnosed with Portopulmonary Hypertension.

Lab values

  • A history of left ventricular ejection fraction (LVEF) ≤ 40% on echocardiogram within 12 months of screening, or clinically significant ischemic, mitral or aortic valve disease, or constrictive heart disease, in the opinion of the Investigator

Other

  • Pregnant or breast-feeding females

Who the study is looking for

  • Male or female between 18 and 75 years of age inclusive at the Screening Visit
  • A diagnosis of PAH belonging to one of the subgroups of the NICE classification of Group 1*: a. I/HPAH, PAH-CTD, b. PAH due to drugs and/or toxins/chemicals (having been in the care of the investigator for at least one year with no relapses of drug or toxin/chemical abuse), c. HIV associated or d. PAH due to repaired congenital heart disease (at least 1 year since repair). *Excluding patients with Portopulmonary Hypertension
  • World Health Organization (WHO) Functional Class II, III or IV symptoms
  • Must be able to walk a distance of at least 100 m but no more than 475 m during the screening 6-minute walk test.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (46)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of Vienna
Coordinator of this site? Confirm its status
ViennaAustriaCompleted
Hopital Erasme
Coordinator of this site? Confirm its status
AnderlechtBelgiumCompleted
UZ Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumCompleted
Vseobecna fakultni nemocnice v Praze
Coordinator of this site? Confirm its status
PragueCzechiaCompleted
University Hospital Cologne AöR
Coordinator of this site? Confirm its status
CologneGermanyCompleted
Technische Universität Dresden
Coordinator of this site? Confirm its status
DresdenGermanyCompleted
Justus-Liebig-Universitaet Giessen
Coordinator of this site? Confirm its status
GiessenGermanyCompleted
Thoraxklinik Heidelberg gGmbH
Coordinator of this site? Confirm its status
HeidelbergGermanyCompleted
Muenchen Klinik gGmbH
Coordinator of this site? Confirm its status
MunichGermanyCompleted
Hospital Clinic de Barcelona
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
El Hospital Universitario De Gran Canaria Dr. Negrin
Coordinator of this site? Confirm its status
Las Palmas De Gran CanariaSpainCompleted
Hospital Universitario Ramón y Cajal
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario 12 de Octubre
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario La Paz
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario Virgen de la Victoria
Coordinator of this site? Confirm its status
MálagaSpainCompleted
Hospital Universitario De Salamanca
Coordinator of this site? Confirm its status
SalamancaSpainCompleted
Hospital Universitario Marqués de Valdecilla
Coordinator of this site? Confirm its status
SantanderSpainCompleted
Hospital Universitario de Toledo
Coordinator of this site? Confirm its status
ToledoSpainCompleted
Hospices Civils de Lyon
Coordinator of this site? Confirm its status
BronFranceCompleted
Bicetre Hospital
Coordinator of this site? Confirm its status
Le Kremlin Bicetre CedexFranceCompleted
Assistance Publique Hôpitaux de Marseille
Coordinator of this site? Confirm its status
MarseilleFranceCompleted
Centre Hospitalier Universitaire De Montpellier
Coordinator of this site? Confirm its status
Montpellier Cedex 5FranceCompleted
Les Hopitaux Universitaires De Strasbourg
Coordinator of this site? Confirm its status
Strasbourg CedexFranceCompleted
Evangelismos S A
Coordinator of this site? Confirm its status
AthensGreeceCompleted
Onassis Cardiac Surgery Center
Coordinator of this site? Confirm its status
KallitheaGreeceCompleted
University General Hospital of Thessaloniki - AHEPA
Coordinator of this site? Confirm its status
ThessalonikiGreeceCompleted
Mater Misericordiae University Hospital
Coordinator of this site? Confirm its status
Dublin 7IrelandCompleted
Azienda Ospedaliero Universitaria Ospedali Riuniti
Coordinator of this site? Confirm its status
FoggiaItalyCompleted
Multimedica S.p.A.
Coordinator of this site? Confirm its status
MilanItalyCompleted
Fondazione IRCCS San Gerardo dei Tintori
Coordinator of this site? Confirm its status
MonzaItalyCompleted
Azienda Ospedaliera dei Colli
Coordinator of this site? Confirm its status
NaplesItalyCompleted
Istituto Mediterraneo Per I Trapianti E Terapie Ad Alta Specializzazione S.r.l. I.S.M.E.T.T. S.r.l.
Coordinator of this site? Confirm its status
PalermoItalyCompleted
Fondazione IRCCS Policlinico San Matteo
Coordinator of this site? Confirm its status
PaviaItalyCompleted
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Coordinator of this site? Confirm its status
RomeItalyCompleted
Pauls Stradins Clinical University Hospital
Coordinator of this site? Confirm its status
RigaLatviaCompleted
Amsterdam UMC
Coordinator of this site? Confirm its status
AmsterdamNetherlandsCompleted
Krakowski Szpital Specjalistyczny Im. Sw. Jana Pawla II
Coordinator of this site? Confirm its status
CracowPolandCompleted
Wojewodzki Specjalistyczny Szpital Im Dr Wl Bieganskiego
Coordinator of this site? Confirm its status
LodzPolandCompleted
Uniwersytecki Szpital Kliniczny w Poznaniu
Coordinator of this site? Confirm its status
PoznanPolandCompleted
Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu
Coordinator of this site? Confirm its status
WroclawPolandCompleted
Hospital Garcia De Orta E.P.E.
Coordinator of this site? Confirm its status
AlmadaPortugalCompleted
Centro Hospitalar E Universitărio de Coimbra E.P.E.
Coordinator of this site? Confirm its status
CoimbraPortugalCompleted
Centro Hospitalar Universitario De Lisboa Norte E.P.E.
Coordinator of this site? Confirm its status
LisbonPortugalCompleted
Centro Hospitalar Universitário de Santo Antonio,E.P.E.
Coordinator of this site? Confirm its status
PortoPortugalCompleted
Region Vaesterbotten
Coordinator of this site? Confirm its status
UmeaSwedenCompleted

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.